{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-116676","form_type":"8-K","ticker":"CLB","cik":"0001958086","company_name":"Core Laboratories Inc. /DE/","filed_at":"2024-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.438933+00:00","generated_at":"2026-05-30T11:12:31.697119+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Core Lab Q3 revenue $134.4M +7% YoY; EPS ex-items $0.25 +14% YoY; net debt reduced","bullets":["Revenue $134.4M, up 3% sequentially and over 7% year-over-year.","Operating income ex-items $18.2M, up 11% sequentially and 14% YoY; margins 14%.","GAAP EPS $0.25; ex-items $0.25, up 14% sequentially and YoY.","Free cash flow $10.4M; net debt reduced $11.8M; debt leverage ratio 1.47.","Declares Q4 dividend $0.01/share, payable Nov 25 to holders of record Nov 4."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-116676","json":"https://secwatch.observer/filing/0000950170-24-116676.json","markdown":"https://secwatch.observer/filing/0000950170-24-116676.md","text":"https://secwatch.observer/filing/0000950170-24-116676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958086/000095017024116676/0000950170-24-116676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958086/000095017024116676/clb-20241023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:12:31.697119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}